Volume 23, Supplement—December 2017
Global Health Security Supplement
CDC Activities for Improving Implementation of Human Papillomavirus Vaccination, Cervical Cancer Screening, and Surveillance Worldwide
- International Agency for Research on Cancer. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC Cancer Base No. 11, 2013. Lyon (France): International Agency for Research on Cancer 2014 [cited 2017 Sep 27]. http://publications.iarc.fr/Databases/Iarc-Cancerbases/Globocan-2012-Estimated-Cancer-Incidence-Mortality-And-Prevalence-Worldwide-In-2012-V1-0-2012
- Schlecht NF, Kulaga S, Robitaille J, Ferreira S, Santos M, Miyamura RA, et al. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA. 2001;286:3106–14.
- Saraiya M, Unger ER, Thompson TD, Lynch CF, Hernandez BY, Lyu CW, et al.; HPV Typing of Cancers Workgroup. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines. J Natl Cancer Inst. 2015;107:djv086.
- Schiffman M, Kjaer SK. Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia. J Natl Cancer Inst Monogr. 2003;31:14–9.
- Gakidou E, Nordhagen S, Obermeyer Z. Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities. PLoS Med. 2008;5:e132.
- International Agency for Research on Cancer. IARC handbooks of cancer prevention. Vol. 10 [cited 2017 Sep 27]. http://www.iarc.fr/en/publications/pdfs-online/prev/handbook10/
- World Health Organization. Immunization vaccines and biologicals database, April 2017. Geneva: The Organization; 2017.
- World Health Organization. Guidelines for screening and treatment of precancerous lesions for cervical cancer prevention, 2013 [cited 2017 Sep 27]. http://www.who.int/reproductivehealth/publications/cancers/screening_and_treatment_of_precancerous_lesions/en/
- Council on Foreign Relations. The emerging global health crisis: noncommunicable diseases in low-and middle-income countries, 2014. Independent Task Force Report No. 72 [cited 2017 Sep 27]. http://www.cfr.org/diseases-noncommunicable/emerging-global-health-crisis/p33883
- Centers for Disease Control and Prevention. CDC’s strategic framework for global immunization, 2016–2020, 2016 [cited 2017 Sep 27]. https://www.cdc.gov/globalhealth/immunization/docs/global-immunization-framework-508.pdf
- Human papillomavirus vaccines. WHO position paper. Wkly Epidemiol Rec. 2009;84:118–31.
- World Health Organization. Report of the meeting on HPV vaccine coverage and impact monitoring, November 16–17, 2009. Geneva: The Organization; 2010 [cited 2017 Oct 19] http://apps.who.int/iris/bitstream/10665/70305/1/WHO_IVB_10.05_eng.pdf
- World Health Organization. Recommendations to assure the quality, safety and efficacy of recombinant human papillomavirus virus-like particle vaccines. Geneva: The Organization; 2015 [cited 2017 Oct 19]. http://www.who.int/biologicals/IPV_FINAL_for_BS2233_07072014(2).pdf
- Gavi, The Vaccine Alliance. Human papillomavirus vaccine support, 2017 [cited 2017 Feb 15]. http://www.gavi.org/support/nvs/human-papillomavirus/
- PATH Publications and London School of Hygiene and Tropical Medicine. HPV vaccine lessons learned. RHO Cervical Cancer, 2014–2016 [cited 2017 Feb 15]. http://www.rho.org/HPVlessons/
- Meeting of the Strategic Advisory Group of Experts on Immunization. October 2016: conclusions and recommendations. Wkly Epidemiol Rec. 2016;91:561–82.
- Friedman AL, Oruko KO, Habel MA, Ford J, Kinsey J, Odhiambo F, et al. Preparing for human papillomavirus vaccine introduction in Kenya: implications from focus-group and interview discussions with caregivers and opinion leaders in Western Kenya. BMC Public Health. 2014;14:855.
- Centers for Disease Control and Prevention (CDC). Progress toward implementation of human papillomavirus vaccination—the Americas, 2006-2010. MMWR Morb Mortal Wkly Rep. 2011;60:1382–4.
- Markowitz LE, Tsu V, Deeks SL, Cubie H, Wang SA, Vicari AS, et al. Human papillomavirus vaccine introduction—the first five years. Vaccine. 2012;30(Suppl 5):F139–48.
- Pan American Health Organization/World Health Organization/Centers for Disease Control and Prevention. Integrating HPV testing in cervical cancer screening programs: a manual for program managers, 2016 [cited 2017 Sep 27]. http://iris.paho.org/xmlui/handle/123456789/31393
- Joint United Nations Programme on HIV and AIDS. The George W. Bush Institute, the U.S. Department of State, Susan G. Komen for the Cure, and UNAIDS announce a new women’s health initiative (press release) [cited 2017 Sep 27]. http://www.unaids.org/en/resources/presscentre/pressreleaseandstatementarchive/2011/september/20110913pinkribbonredribbon
- Sangrajrang S, Laowahutanont P, Wongsena M, Muwonge R, Karalak A, Imsamran W, et al. Comparative accuracy of Pap smear and HPV screening in Ubon Ratchathani in Thailand. Papillomavirus Res. 2017;3:30–5.
- Drummond JL, Were MC, Arrossi S, Wools-Kaloustian K. Cervical cancer data and data systems in limited-resource settings: Challenges and opportunities. Int J Gynaecol Obstet. 2017;138(Suppl 1):33–40.
- Centers for Disease Control and Prevention. CDC Foundation and George W. Bush Institute partner in $3.6 million grant to address global cervical cancer. April 16, 2014 [cited 2017 Sep 27]. https://www.cdcfoundation.org/pr/2014/cdc-foundation-bush-institute-partnership-to-address-global-cervical-cancer
- Centers for Disease Control and Prevention Foundation. Improving data for decision-making in global cervical cancer programs (IDCCP). Accelerating action on human papillomavirus and cervical cancer prevention and control (APEC) Conference: Implementing Policy Recommendations Workshop; August 23, 2016; Lima, Peru [cited 2017 Sep 27]. http://mddb.apec.org/Documents/2016/HWG/HWG-LSIF-WKSP/16_hwg-lsif_wksp_006.pdf
- Joseph R, Manosoontorn S, Petcharoen N, Sangrajrang S, Senkomago V, Saraiya M. Assessing cervical cancer screening coverage using a population-based behavioral risk factor survey—Thailand, 2010. J Womens Health (Larchmt). 2015;24:966–8.
- Wang B, He M, Chao A, Engelgau MM, Saraiya M, Wang L, et al. Cervical cancer screening among adult women in China, 2010. Oncologist. 2015;20:627–34.
- Buchanan Lunsford N, Ragan K, Lee Smith J, Saraiya M, Aketch M. Environmental and psychosocial barriers to and benefits of cervical cancer screening in Kenya. Oncologist. 2017;22:173–81.
- Centers for Disease Control and Prevention. Field Epidemiology Training Program: where we work [cited 2017 Feb 17]. https://www.cdc.gov/globalhealth/healthprotection/fetp/where/index.html
- The Cancer Atlas. Reliable monitoring of cancer cases and deaths is essential for successful cancer management plans, 2017 [cited 2017 Sep 27]. http://canceratlas.cancer.org/taking-action/cancer-registries/
- International Agency for Research on Cancer (IARC). WHO global initiative for cancer registry development (GICR), 2017 [cited 2017 Sep 27]. http://gicr.iarc.fr/
- Saraiya M, Tangka FK, Asma S, Richardson LC. Importance of economic evaluation of cancer registration in the resource limited setting: Laying the groundwork for surveillance systems. Cancer Epidemiol. 2016;45(Suppl 1):S1–3.